financial instruments, the contractual cash flow characteristics and the business model.  Impairment assessment using the expected credit loss approach. The instruments that are in the scope of impairment

of the Board Charter and disclose the full version of such information in the attachment herein. 7.3 Information on subcommittees Describe the composition of the subcommittees, showing the scope of

แบบแสดงรายการข้อมูลการเสนอขายหลักทรัพย์ (Unofficial Translation) Readers should be aware that only the original Thai text has legal force and that this English translation is strictly for reference. SEC Classification : ใชภ้ายใน (Internal) FORM 56-1 One Report (Attached to Notification No. Tor Jor. 55/2563) Applicable to the Financial Year Ending 31 December 2021 onwards Annual Registration Statement / Annual Report Form 56-1 One Report Form 69-1 1 September 2020 Note: This annual registration s...

million for the year 2017 and 2016, respectively. To this extent, the Company would like to provide the following explanations.  Revenue from sales and cost of goods sold The Company recorded a sales

THB 1,048 million for the year 2017 and 2016, respectively. The Company (separate) reports a net loss of THB 1,006 million and THB 1,097 million for the year 2017 and 2016, respectively. To this extent

495 million and THB 155 million for the 3rd quarter of 2017 and 2016, respectively. To this extent, the Company would like to provide the following explanations.  Revenue from sales and cost of goods

: Rules, Conditions and Procedures for Securities Underwriting dated 11 July 2003 which have been in effect prior to the effective date of this Notification shall remain in full force to the extent that

this Notification shall remain in full force to the extent that they are not inconsistent with nor contrary to the provisions of this Notification until notifications, orders and circulars issued under

full force to the extent that they are not inconsistent with nor contrary to the provisions of this Notification until notifications, orders and circulars issued under or prescribing guidelines for

dated 11 July 2003 which are in effect prior to the effective date of this Notification shall remain in full force to the extent that they are not inconsistent with nor contrary to the provisions of this